According to Shikha Jain, MD, an oncologist from Northwestern Memorial Hospital in Chicago, “The long-term outcomes from the BRIGHT study are very exciting. R-CHOP/R-CVP have been the standard of care for many less aggressive lymphomas for years.”
Source: ASCO 2017: June 4 Highlights
